Localization of 7B2, neuromedin B, and neuromedin U in specific cell types of rat, mouse, and human pituitary, in rat hypothalamus, and in 30 human pituitary and extrapituitary tumors.
The distributions of three novel peptides, 7B2, neuromedin B, and neuromedin U, in rat, mouse, and human pituitaries, rat hypothalamus, and 30 human pituitary tumors were investigated with immunocytochemistry. Immunoreactivity for 7B2 was present in rat, mouse, and human gonadotropes, in intermediate lobe cells and posterior lobe nerve fibers in rats and mice, in rat hypothalamus (particularly in the median eminence), and in eight human pituitary gonadotropinomas. In gonadectomized rats, larger, more numerous LH beta- and 7B2-immunoreactive gonadotropes were seen than in controls. Extractable 7B2-like immunoreactivity was elevated but not significantly so in gonadectomized rat pituitaries [males: castrated, 37.4 +/- 4.3 (mean +/- SE); controls, 26.9 +/- 4.3; females: ovariectomized, 27.2 +/- 2.7; controls, 19.1 +/- 2.2 pmol/gland]. Neuromedin B immunoreactivity was found in normal rat and mouse thyrotropes and weakly in "thyroidectomy" cells in hypothyroid rats, in which extractable pituitary neuromedin B was significantly depleted (thyroidectomized, 87.0 +/- 14.0; methimazole-treated, 82.0 +/- 11.4; control, 230.7 +/- 25.6 fmol/gland). Hyperthyroid rat pituitaries showed increased TSH beta and neuromedin B immunoreactivities and neuromedin B content (TRH-treated, 385.2 +/- 30.2; T4-treated, 352.6 +/- 20.2; control, 230.7 +/- 25.6 fmol/gland). Neuromedin U immunoreactivity occurred in corticotropes of all species, in rat and mouse intermediate lobe, and throughout the rat hypothalamus, with immunoreactive cell bodies in the arcuate nucleus. Neuromedin U-immunoreactive cells were present in six of six human pituitary and five of six human extrapituitary corticotropinomas. In adrenalectomized rats, corticotropes were larger and more numerous than in controls, but extractable anterior pituitary neuromedin U-like immunoreactivity was not raised (adrenalectomized, 3.30 +/- 0.45; control, 3.32 +/- 0.27 pmol/gland). Our findings suggest that 7B2, neuromedin B, and neuromedin U may be involved in pituitary function.
Steel
J H
JH
Department of Histochemistry, Royal Postgraduate Medical School, Hammersmith Hospital, London, England.
Van Noorden
S
S
Ballesta
J
J
Gibson
S J
SJ
Ghatei
M A
MA
Burrin
J
J
Leonhardt
U
U
Domin
J
J
Bloom
S R
SR
Polak
J M
JM
D000818:Animals; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000166:cytology*; D008297:Male; D009369:Neoplasms / Q000473:pathology*; D009419:Nerve Tissue Proteins; D051859:Neuroendocrine Secretory Protein 7B2; D015287:Neurokinin B / Q000031:analogs & derivatives*; D009479:Neuropeptides / Q000032:analysis*; D009919:Orchiectomy; D009928:Organ Specificity; D010052:Ovariectomy; D010902:Pituitary Gland / Q000166:cytology*; D010907:Pituitary Hormones / Q000032:analysis*; D010911:Pituitary Neoplasms / Q000473:pathology*; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D013045:Species Specificity
D009419:Nerve Tissue Proteins; D051859:Neuroendocrine Secretory Protein 7B2; D009479:Neuropeptides; D010907:Pituitary Hormones; C497678:SCG5 protein, human; C497680:Scg5 protein, rat; D015287:Neurokinin B; C038393:neuromedin B; C046270:neuromedin U 8; C046271:neuromedin U 25